| Identification | Back Directory | [Name]
4-[(TERT-BUTOXYCARBONYL)(METHYL)AMINO]BUTANOIC ACID | [CAS]
94994-39-5 | [Synonyms]
Boc-N-Me-GABA 4-[N-Boc-(methylamino)]butanoic acid (Tert-Butoxy)Carbonyl N-Me-Abu(4)-OH Boc-N-methyl-gamma-aminobutyric acid 4-(N-BOC-N-METHYL-AMINO)-BUTYRIC ACID 4-[(TERT-BUTOXYCARBONYL)(METHYL)AMINO]BUTANOIC ACID Butanoic acid, 4-[[(1,1-dimethylethoxy)carbonyl]methylamino]- | [Molecular Formula]
C10H19NO4 | [MDL Number]
MFCD09831984 | [MOL File]
94994-39-5.mol | [Molecular Weight]
217.26 |
| Chemical Properties | Back Directory | [Boiling point ]
332.5±21.0 °C(Predicted) | [density ]
1.091±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [pka]
4.70±0.10(Predicted) | [Appearance]
White to off-white Solid |
| Hazard Information | Back Directory | [Uses]
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic Acid is used in preparation of substituted straight chain spiro derivatives as menin/MLL protein/protein interaction inhibitors useful for treating diseases. | [Synthesis]
At room temperature, 4-(methylamino)butyric acid hydrochloride (1.00 g, 6.51 mmol) and triethylamine (2.72 mL, 19.5 mmol) were dissolved in dichloromethane (60 mL) and mixed with stirring. Subsequently, di-tert-butyl dicarbonate (1.56 g, 7.16 mmol) was slowly added to the mixture. The reaction mixture was stirred continuously at room temperature for about 72 hours. The reaction progression was monitored by LC-MS to confirm product formation (retention time 4.11 min; m/z 216.2 [M + H]+). Upon completion of the reaction, dichloromethane and water were added for dilution, and the pH of the aqueous layer was adjusted to 4.5-6.0 with 1 M aqueous hydrochloric acid.The organic and aqueous layers were separated, and the organic layer was dried over anhydrous sodium sulfate, filtered, and then concentrated under reduced pressure to afford 4-(tert-butoxycarbonyl(methyl)amino)butyric acid (1.5 g, 100% yield) as a light yellow thick oil.1H NMR (CDCl3) δ: 3.28 (broad peak, 1H), 2.85 (single peak, 3H), 2.35 (triple peak, 2H), 1.84 (triple peak, 2H), 1.46 (single peak, 9H). | [References]
[1] Patent: WO2010/123766, 2010, A1. Location in patent: Page/Page column 59 [2] Patent: US2009/48147, 2009, A1. Location in patent: Page/Page column 41 [3] Patent: US2003/220341, 2003, A1. Location in patent: Page/Page column 32-33 [4] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 3, p. 1376 - 1392 [5] Patent: EP881220, 1998, A1 |
|
|